Introducing the CooperVision MiSight® 1 day, the first and only FDA approved product specifically designed to slow the progression of myopia in children aged 8-12 at the initiation of treatment. This innovative solution is here to revolutionize the way we approach myopia in younger individuals. With an easy-to-fit design and a single-use lens, it offers utmost convenience and comfort for both parents and children alike. Not only does it correct refractive error, but it also effectively slows the elongation of the eye through the advanced ActivControl TM Technology. This cutting-edge technology ensures that the progression of myopia is significantly reduced, providing children with clearer vision and preserving the health of their eyes. Trust in the expertise of CooperVision to deliver a superior solution that empowers parents and enhances the quality of life for young ones.